Fairmount Funds Management’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-5,163,287
| Closed | -$11.3M | – | 20 |
|
|
2023
Q3 | $11.3M | Sell |
5,163,287
-27,073
| -0.5% | -$59K | 1.35% | 17 |
|
|
2023
Q2 | $12.4M | Sell |
5,190,360
-506,155
| -9% | -$1.21M | 1.75% | 14 |
|
|
2023
Q1 | $10.5M | Hold |
5,696,515
| – | – | 1.81% | 15 |
|
|
2022
Q4 | $11M | Hold |
5,696,515
| – | – | 1.74% | 13 |
|
|
2022
Q3 | $8.77M | Buy |
5,696,515
+4,072,126
| +251% | +$6.27M | 1.54% | 20 |
|
|
2022
Q2 | $4.57M | Buy |
+1,624,389
| New | +$4.56M | 1.04% | 22 |
|